secwatch / observer
8-K filed September 1, 2021, 7:59 PM ET ticker BHIC CIK 0001784440
other material confidence high sentiment neutral materiality 0.85

Nowtransit Inc. change of control: Justin Earl acquires 51.3% stake, becomes President and sole director

BioScience Health Innovations, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Ivan Homici

President
BHIC · BioScience Health Innovations, Inc.
Effective
2021-07-29
Successor
Justin Earl
Filed
September 1, 2021, 7:59 PM ET
On July 29, 2021, Mr. Homici resigned as the Company’s director, President, Treasurer and Secretary and was replaced in each such role by Mr. Earl.
Appointed

Justin Earl

President
BHIC · BioScience Health Innovations, Inc.
Effective
2021-07-29
Filed
September 1, 2021, 7:59 PM ET
On July 29, 2021, Mr. Homici resigned as the Company’s director, President, Treasurer and Secretary and was replaced in each such role by Mr. Earl.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Ivan Homici resigned as President at BioScience Health Innovations, Inc..

Action
resigned
Role
President
Exact text from the filing
On July 29, 2021, Mr. Homici resigned as the Company’s director, President, Treasurer and Secretary and was replaced in each such role by Mr. Earl.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Justin Earl was appointed as President at BioScience Health Innovations, Inc..

Action
appointed
Role
President
Exact text from the filing
On July 29, 2021, Mr. Homici resigned as the Company’s director, President, Treasurer and Secretary and was replaced in each such role by Mr. Earl.
View on SEC.gov

BioScience Health Innovations, Inc. filing history →

Source: SEC EDGAR
accession 0001185185-21-001231
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.